Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine – A retrospective single center experience
Michael Leisch(Paracelsus Medical University), Lisa Pleyer(Paracelsus Medical University), Christof Jungbauer(Paracelsus Medical University), Christoph Grabmer(Paracelsus Medical University), Richard Greil(Paracelsus Medical University), Nadja Lindlbauer(Paracelsus Medical University), Eva Rohde(Medical University of Graz)
Cited by 20
Related Papers
Concise Review: Developing Best-Practice Models for the Therapeutic Use of Extracellular Vesicles
|Stem Cells Translational Medicine|2017|359
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
|The Lancet Haematology|2020|351
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
|The Lancet Infectious Diseases|2021|344
Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas
|International Journal of Mass Spectrometry|2007|276